Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry

A simple liquid chromatography−quadrupole-time-of-flight−mass spectrometric assay (LC-TOF-MS/MS) has been developed for the evaluation of metabolism and pharmacokinetic (PK) characteristics of monomethyl auristatin F (MMAF) in rat, which is being used as a payload for antibody-dr...

Full description

Bibliographic Details
Main Authors: Min-Ho Park, Byeong ill Lee, Jin-Ju Byeon, Seok-Ho Shin, Jangmi Choi, Yuri Park, Young G. Shin
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/24/15/2754
_version_ 1819037649960173568
author Min-Ho Park
Byeong ill Lee
Jin-Ju Byeon
Seok-Ho Shin
Jangmi Choi
Yuri Park
Young G. Shin
author_facet Min-Ho Park
Byeong ill Lee
Jin-Ju Byeon
Seok-Ho Shin
Jangmi Choi
Yuri Park
Young G. Shin
author_sort Min-Ho Park
collection DOAJ
description A simple liquid chromatography−quadrupole-time-of-flight−mass spectrometric assay (LC-TOF-MS/MS) has been developed for the evaluation of metabolism and pharmacokinetic (PK) characteristics of monomethyl auristatin F (MMAF) in rat, which is being used as a payload for antibody-drug conjugates. LC-TOF-MS/MS method was qualified for the quantification of MMAF in rat plasma. The calibration curves were acceptable over the concentration range from 3.02 to 2200 ng/mL using quadratic regression. MMAF was stable in various conditions. There were no significant matrix effects between rat and other preclinical species. The PK studies showed that the bioavailability of MMAF was 0% with high clearance. Additionally, the metabolite profiling studies, in vitro/in vivo, were performed. Seven metabolites for MMAF were tentatively identified in liver microsome. The major metabolic pathway was demethylation, which was one of the metabolic pathways predicted by MedChem Designer. Therefore, these results will be helpful to understand the PK, catabolism, and metabolism behavior of MMAF comprehensively when developing antibody-drug conjugates (ADCs) in the future.
first_indexed 2024-12-21T08:24:47Z
format Article
id doaj.art-1937c08029fd4848b762197dda7acf70
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-21T08:24:47Z
publishDate 2019-07-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-1937c08029fd4848b762197dda7acf702022-12-21T19:10:21ZengMDPI AGMolecules1420-30492019-07-012415275410.3390/molecules24152754molecules24152754Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass SpectrometryMin-Ho Park0Byeong ill Lee1Jin-Ju Byeon2Seok-Ho Shin3Jangmi Choi4Yuri Park5Young G. Shin6College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, KoreaCollege of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, KoreaCollege of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, KoreaCollege of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, KoreaCollege of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, KoreaCollege of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, KoreaCollege of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, KoreaA simple liquid chromatography−quadrupole-time-of-flight−mass spectrometric assay (LC-TOF-MS/MS) has been developed for the evaluation of metabolism and pharmacokinetic (PK) characteristics of monomethyl auristatin F (MMAF) in rat, which is being used as a payload for antibody-drug conjugates. LC-TOF-MS/MS method was qualified for the quantification of MMAF in rat plasma. The calibration curves were acceptable over the concentration range from 3.02 to 2200 ng/mL using quadratic regression. MMAF was stable in various conditions. There were no significant matrix effects between rat and other preclinical species. The PK studies showed that the bioavailability of MMAF was 0% with high clearance. Additionally, the metabolite profiling studies, in vitro/in vivo, were performed. Seven metabolites for MMAF were tentatively identified in liver microsome. The major metabolic pathway was demethylation, which was one of the metabolic pathways predicted by MedChem Designer. Therefore, these results will be helpful to understand the PK, catabolism, and metabolism behavior of MMAF comprehensively when developing antibody-drug conjugates (ADCs) in the future.https://www.mdpi.com/1420-3049/24/15/2754MMAFADCbioanalysismetabolismpharmacokinetics
spellingShingle Min-Ho Park
Byeong ill Lee
Jin-Ju Byeon
Seok-Ho Shin
Jangmi Choi
Yuri Park
Young G. Shin
Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry
Molecules
MMAF
ADC
bioanalysis
metabolism
pharmacokinetics
title Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry
title_full Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry
title_fullStr Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry
title_full_unstemmed Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry
title_short Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry
title_sort pharmacokinetic and metabolism studies of monomethyl auristatin f via liquid chromatography quadrupole time of flight mass spectrometry
topic MMAF
ADC
bioanalysis
metabolism
pharmacokinetics
url https://www.mdpi.com/1420-3049/24/15/2754
work_keys_str_mv AT minhopark pharmacokineticandmetabolismstudiesofmonomethylauristatinfvialiquidchromatographyquadrupoletimeofflightmassspectrometry
AT byeongilllee pharmacokineticandmetabolismstudiesofmonomethylauristatinfvialiquidchromatographyquadrupoletimeofflightmassspectrometry
AT jinjubyeon pharmacokineticandmetabolismstudiesofmonomethylauristatinfvialiquidchromatographyquadrupoletimeofflightmassspectrometry
AT seokhoshin pharmacokineticandmetabolismstudiesofmonomethylauristatinfvialiquidchromatographyquadrupoletimeofflightmassspectrometry
AT jangmichoi pharmacokineticandmetabolismstudiesofmonomethylauristatinfvialiquidchromatographyquadrupoletimeofflightmassspectrometry
AT yuripark pharmacokineticandmetabolismstudiesofmonomethylauristatinfvialiquidchromatographyquadrupoletimeofflightmassspectrometry
AT younggshin pharmacokineticandmetabolismstudiesofmonomethylauristatinfvialiquidchromatographyquadrupoletimeofflightmassspectrometry